DÉRIVÉS DE 3-(2-AMINOPYRIMIDIN-4-YL)-5-(3-HYDROXYPROPYNYL)-1H-PYRROLO[2,3-C]PYRIDINE COMME INHIBITEURS DE LA NIK POUR LE TRAITEMENT DU CANCER

• 收藏
• 分享

专利权人:

Janssen Pharmaceutica NV

发明人:

申请号：

EP14719024.3

公开号：

EP2989101B1

申请日:

2014.04.24

申请国别(地区):

EP

年份:

2019

代理人:

摘要：

The present invention relates to compounds of formula (I) which are inhibitors of NF-KB-inducing kinase (NIK&mdash；also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/